Drug-induced hemolytic uremic syndrome
- PMID: 21769182
- PMCID: PMC3132338
- DOI: 10.4103/0971-4065.82377
Drug-induced hemolytic uremic syndrome
Figures


References
-
- Aravindan A, Yong J, Killingsworth M, Suranyi M, Wong J. Minimal change disease with interferon-beta therapy for relapsing remitting multiple sclerosis. NDT Plus. 2010;3:132–4.
-
- Magee CC. Renal thrombotic microangiopathy induced by interferon alpha. Nephrol Dial Transplant. 2001;16:2111–2. - PubMed
-
- Badid C, McGregor B, Faivre JM, Guerard A, Juillard L, Fouque D, et al. Renal thrombotic microangiopathy induced by interferon-alpha. Nephrol Dial Transplant. 2001;16:846–8. - PubMed
-
- Vacher-Coponat H, Opris A, Daniel L, Harle JR, Veit V, Olmer M. Thrombotic microangiopathy in a patient with chronic myelocitic leukemia treated with alpha-interferon. Nephrol Dial Transplant. 1999;14:2469–71. - PubMed
-
- Galesic K, Bozic B, Racic I, Scukanec-Spoljar M. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukemia. Nephrology (Carlton) 2006;11:49–52. - PubMed